| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 29 | 2022 | 1377 | 3.110 |
Why?
|
| Breast Neoplasms | 19 | 2026 | 1723 | 2.800 |
Why?
|
| Uterine Cervical Neoplasms | 10 | 2023 | 367 | 2.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2026 | 47 | 1.920 |
Why?
|
| Colorectal Neoplasms | 8 | 2023 | 512 | 1.910 |
Why?
|
| Early Detection of Cancer | 12 | 2023 | 449 | 1.750 |
Why?
|
| Health Knowledge, Attitudes, Practice | 19 | 2021 | 989 | 1.610 |
Why?
|
| Humans | 104 | 2026 | 43102 | 1.470 |
Why?
|
| Female | 77 | 2026 | 24698 | 1.400 |
Why?
|
| Clinical Trials as Topic | 9 | 2025 | 259 | 1.390 |
Why?
|
| Language | 6 | 2018 | 185 | 1.350 |
Why?
|
| Mass Screening | 7 | 2021 | 541 | 1.320 |
Why?
|
| Adult | 50 | 2026 | 13872 | 1.310 |
Why?
|
| Skin Neoplasms | 4 | 2024 | 178 | 1.280 |
Why?
|
| Islets of Langerhans | 4 | 2026 | 16 | 1.280 |
Why?
|
| Continuity of Patient Care | 8 | 2022 | 120 | 1.260 |
Why?
|
| HIV Infections | 5 | 2023 | 2586 | 1.260 |
Why?
|
| Middle Aged | 50 | 2026 | 12222 | 1.200 |
Why?
|
| Biological Specimen Banks | 4 | 2018 | 28 | 1.140 |
Why?
|
| Alternative Splicing | 2 | 2026 | 94 | 1.130 |
Why?
|
| Patient Education as Topic | 4 | 2015 | 235 | 1.130 |
Why?
|
| Psychometrics | 12 | 2023 | 358 | 1.130 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 486 | 1.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2026 | 154 | 1.040 |
Why?
|
| Health Services Accessibility | 13 | 2015 | 706 | 1.030 |
Why?
|
| Male | 53 | 2026 | 23409 | 1.020 |
Why?
|
| Sunbathing | 2 | 2024 | 8 | 0.990 |
Why?
|
| Self Efficacy | 8 | 2018 | 215 | 0.980 |
Why?
|
| Healthcare Disparities | 11 | 2017 | 590 | 0.970 |
Why?
|
| Patient Satisfaction | 9 | 2019 | 165 | 0.920 |
Why?
|
| Medication Adherence | 2 | 2026 | 182 | 0.900 |
Why?
|
| Caregivers | 6 | 2025 | 197 | 0.880 |
Why?
|
| Insulin-Secreting Cells | 4 | 2026 | 28 | 0.870 |
Why?
|
| Patient Acceptance of Health Care | 8 | 2025 | 497 | 0.870 |
Why?
|
| Qualitative Research | 9 | 2026 | 574 | 0.860 |
Why?
|
| Young Adult | 21 | 2026 | 5080 | 0.830 |
Why?
|
| Thymus Gland | 2 | 2020 | 76 | 0.780 |
Why?
|
| Aged | 28 | 2026 | 8214 | 0.740 |
Why?
|
| Internal-External Control | 2 | 2018 | 63 | 0.730 |
Why?
|
| Breast Feeding | 3 | 2013 | 126 | 0.720 |
Why?
|
| United States | 20 | 2025 | 5205 | 0.690 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 117 | 0.680 |
Why?
|
| Biomedical Research | 5 | 2022 | 502 | 0.670 |
Why?
|
| Patient Advocacy | 3 | 2017 | 22 | 0.670 |
Why?
|
| Transcription Factors | 5 | 2025 | 735 | 0.660 |
Why?
|
| Florida | 11 | 2018 | 478 | 0.660 |
Why?
|
| Attitude | 4 | 2016 | 108 | 0.650 |
Why?
|
| Epithelial Cells | 2 | 2020 | 434 | 0.640 |
Why?
|
| Adolescent | 17 | 2025 | 6081 | 0.610 |
Why?
|
| Anxiety | 5 | 2025 | 874 | 0.610 |
Why?
|
| Health Personnel | 3 | 2018 | 277 | 0.610 |
Why?
|
| Rural Population | 3 | 2025 | 373 | 0.600 |
Why?
|
| Patient Participation | 4 | 2013 | 94 | 0.600 |
Why?
|
| Mental Disorders | 1 | 2023 | 392 | 0.590 |
Why?
|
| Vulnerable Populations | 2 | 2017 | 166 | 0.590 |
Why?
|
| Health Education | 5 | 2020 | 363 | 0.590 |
Why?
|
| Heterosexuality | 1 | 2019 | 97 | 0.570 |
Why?
|
| Health Status Disparities | 4 | 2014 | 719 | 0.570 |
Why?
|
| Social Support | 8 | 2025 | 445 | 0.560 |
Why?
|
| Multimedia | 3 | 2013 | 18 | 0.560 |
Why?
|
| Homeodomain Proteins | 3 | 2025 | 150 | 0.550 |
Why?
|
| Brain Neoplasms | 3 | 2025 | 140 | 0.550 |
Why?
|
| Interviews as Topic | 4 | 2026 | 452 | 0.550 |
Why?
|
| Mammography | 2 | 2011 | 212 | 0.550 |
Why?
|
| Famous Persons | 1 | 2017 | 5 | 0.540 |
Why?
|
| Research Subjects | 2 | 2018 | 35 | 0.530 |
Why?
|
| Mastectomy | 1 | 2017 | 21 | 0.530 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2017 | 22 | 0.530 |
Why?
|
| Disclosure | 1 | 2017 | 39 | 0.520 |
Why?
|
| Depression | 6 | 2026 | 863 | 0.520 |
Why?
|
| Melanoma | 1 | 2017 | 110 | 0.480 |
Why?
|
| Cost of Illness | 3 | 2025 | 98 | 0.480 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 186 | 0.470 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2026 | 3 | 0.470 |
Why?
|
| Quality of Health Care | 3 | 2014 | 161 | 0.470 |
Why?
|
| Inservice Training | 1 | 2015 | 33 | 0.470 |
Why?
|
| Primary Health Care | 2 | 2018 | 380 | 0.470 |
Why?
|
| Drug Monitoring | 1 | 2016 | 69 | 0.460 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 10 | 0.450 |
Why?
|
| Mental Health | 1 | 2019 | 385 | 0.450 |
Why?
|
| RNA Splicing | 1 | 2015 | 41 | 0.450 |
Why?
|
| Computers | 1 | 2015 | 35 | 0.440 |
Why?
|
| Sunburn | 2 | 2011 | 5 | 0.440 |
Why?
|
| Minority Health | 2 | 2022 | 95 | 0.440 |
Why?
|
| India | 3 | 2019 | 108 | 0.440 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2015 | 41 | 0.440 |
Why?
|
| Trust | 1 | 2016 | 167 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 92 | 0.430 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 1081 | 0.430 |
Why?
|
| Cross-Sectional Studies | 10 | 2025 | 3156 | 0.430 |
Why?
|
| B-Lymphocytes | 2 | 2025 | 189 | 0.420 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 80 | 0.420 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.420 |
Why?
|
| Stress, Psychological | 4 | 2026 | 661 | 0.420 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 310 | 0.410 |
Why?
|
| Community Health Centers | 2 | 2012 | 57 | 0.410 |
Why?
|
| Autoimmunity | 2 | 2025 | 58 | 0.400 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 54 | 0.400 |
Why?
|
| Interpersonal Relations | 4 | 2025 | 222 | 0.390 |
Why?
|
| Software | 1 | 2015 | 236 | 0.390 |
Why?
|
| Vaginal Smears | 3 | 2019 | 63 | 0.380 |
Why?
|
| Focus Groups | 4 | 2019 | 423 | 0.380 |
Why?
|
| Mice | 10 | 2026 | 6644 | 0.370 |
Why?
|
| Quality of Life | 6 | 2026 | 616 | 0.370 |
Why?
|
| Rural Health Services | 1 | 2012 | 48 | 0.370 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 38 | 0.370 |
Why?
|
| Intention | 4 | 2018 | 108 | 0.360 |
Why?
|
| Decision Making | 4 | 2017 | 249 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 4 | 2026 | 1869 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 760 | 0.340 |
Why?
|
| Research Design | 2 | 2011 | 385 | 0.320 |
Why?
|
| Socioeconomic Factors | 7 | 2018 | 1234 | 0.310 |
Why?
|
| Papillomavirus Infections | 3 | 2021 | 376 | 0.310 |
Why?
|
| Schools | 1 | 2011 | 283 | 0.310 |
Why?
|
| Allied Health Personnel | 1 | 2009 | 5 | 0.300 |
Why?
|
| Telephone | 1 | 2009 | 36 | 0.300 |
Why?
|
| Animals | 12 | 2026 | 16992 | 0.300 |
Why?
|
| Internet | 2 | 2023 | 236 | 0.300 |
Why?
|
| Motivation | 3 | 2017 | 513 | 0.290 |
Why?
|
| Transients and Migrants | 2 | 2021 | 42 | 0.290 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 54 | 0.290 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 375 | 0.280 |
Why?
|
| Diabetes Complications | 1 | 2009 | 102 | 0.280 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2008 | 40 | 0.280 |
Why?
|
| Adaptation, Psychological | 2 | 2026 | 420 | 0.280 |
Why?
|
| Medical Oncology | 3 | 2022 | 50 | 0.270 |
Why?
|
| Survivors | 2 | 2021 | 152 | 0.270 |
Why?
|
| Self Care | 1 | 2009 | 175 | 0.270 |
Why?
|
| Neurons | 1 | 2015 | 1263 | 0.260 |
Why?
|
| Autoantibodies | 2 | 2025 | 117 | 0.260 |
Why?
|
| Communication | 3 | 2019 | 210 | 0.260 |
Why?
|
| Papillomavirus Vaccines | 2 | 2021 | 174 | 0.250 |
Why?
|
| Homosexuality, Male | 2 | 2023 | 486 | 0.250 |
Why?
|
| Attitude to Health | 4 | 2014 | 338 | 0.250 |
Why?
|
| Pregnancy | 4 | 2022 | 1772 | 0.250 |
Why?
|
| Protective Clothing | 3 | 2011 | 6 | 0.250 |
Why?
|
| Cell Differentiation | 4 | 2025 | 638 | 0.250 |
Why?
|
| Immunization Programs | 3 | 2000 | 25 | 0.250 |
Why?
|
| Proglucagon | 1 | 2026 | 2 | 0.250 |
Why?
|
| Psychological Theory | 1 | 2026 | 26 | 0.240 |
Why?
|
| Gene Library | 1 | 2026 | 62 | 0.240 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2025 | 4 | 0.240 |
Why?
|
| Pancreas | 1 | 2026 | 45 | 0.240 |
Why?
|
| Sirtuin 2 | 1 | 2025 | 3 | 0.240 |
Why?
|
| Minority Groups | 4 | 2026 | 690 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2025 | 69 | 0.230 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 2853 | 0.230 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2025 | 25 | 0.230 |
Why?
|
| Recreation | 1 | 2024 | 43 | 0.220 |
Why?
|
| Travel | 1 | 2024 | 36 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 3 | 2018 | 162 | 0.210 |
Why?
|
| Interleukins | 2 | 2021 | 40 | 0.210 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 249 | 0.210 |
Why?
|
| Registries | 3 | 2000 | 437 | 0.210 |
Why?
|
| Cell Lineage | 2 | 2023 | 104 | 0.210 |
Why?
|
| Ferrets | 1 | 2023 | 14 | 0.200 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 28 | 0.200 |
Why?
|
| Transgenes | 1 | 2023 | 65 | 0.200 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 115 | 0.200 |
Why?
|
| Pilot Projects | 3 | 2021 | 760 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 300 | 0.190 |
Why?
|
| Feasibility Studies | 3 | 2025 | 259 | 0.190 |
Why?
|
| Mexico | 1 | 2023 | 298 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2022 | 74 | 0.180 |
Why?
|
| Community Networks | 2 | 2013 | 107 | 0.180 |
Why?
|
| Germinal Center | 1 | 2021 | 12 | 0.180 |
Why?
|
| Infant | 2 | 2022 | 1175 | 0.170 |
Why?
|
| Child | 8 | 2025 | 3443 | 0.170 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 83 | 0.170 |
Why?
|
| Risk Factors | 4 | 2017 | 3994 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2024 | 457 | 0.170 |
Why?
|
| Mexican Americans | 1 | 2023 | 226 | 0.170 |
Why?
|
| Perception | 2 | 2012 | 215 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 1067 | 0.160 |
Why?
|
| Inflammation | 1 | 2026 | 758 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2021 | 192 | 0.160 |
Why?
|
| Lung | 1 | 2023 | 492 | 0.160 |
Why?
|
| Mothers | 1 | 2022 | 215 | 0.160 |
Why?
|
| Blogging | 1 | 2019 | 2 | 0.160 |
Why?
|
| Gene Expression Regulation | 1 | 2025 | 1070 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.150 |
Why?
|
| Ultraviolet Rays | 2 | 2017 | 118 | 0.150 |
Why?
|
| Puerto Rico | 2 | 2013 | 1413 | 0.150 |
Why?
|
| Time Factors | 5 | 2015 | 1857 | 0.150 |
Why?
|
| Spouses | 1 | 2019 | 38 | 0.140 |
Why?
|
| Stereotyping | 1 | 2019 | 45 | 0.140 |
Why?
|
| Fatigue | 1 | 2019 | 100 | 0.140 |
Why?
|
| Interleukin-4 | 1 | 2018 | 75 | 0.140 |
Why?
|
| Cultural Competency | 2 | 2018 | 138 | 0.140 |
Why?
|
| Family | 2 | 2025 | 195 | 0.140 |
Why?
|
| Condoms | 1 | 2019 | 150 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1596 | 0.130 |
Why?
|
| Needs Assessment | 2 | 2013 | 178 | 0.130 |
Why?
|
| Awareness | 1 | 2017 | 73 | 0.130 |
Why?
|
| Models, Psychological | 1 | 2017 | 140 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2017 | 91 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2020 | 549 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 231 | 0.130 |
Why?
|
| Videodisc Recording | 2 | 2013 | 4 | 0.120 |
Why?
|
| Program Evaluation | 2 | 2015 | 359 | 0.120 |
Why?
|
| Pamphlets | 2 | 2013 | 27 | 0.120 |
Why?
|
| Medical Informatics | 1 | 2016 | 25 | 0.120 |
Why?
|
| Consumer Health Information | 1 | 2016 | 24 | 0.120 |
Why?
|
| Health Services Research | 2 | 2014 | 161 | 0.120 |
Why?
|
| Confidentiality | 1 | 2015 | 29 | 0.120 |
Why?
|
| Patient Selection | 2 | 2015 | 205 | 0.120 |
Why?
|
| Personality Inventory | 2 | 2009 | 82 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1028 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2009 | 925 | 0.120 |
Why?
|
| California | 1 | 2017 | 548 | 0.120 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2015 | 43 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2007 | 233 | 0.110 |
Why?
|
| Cilia | 1 | 2015 | 31 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2015 | 48 | 0.110 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 95 | 0.110 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2014 | 19 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2015 | 139 | 0.110 |
Why?
|
| Models, Educational | 1 | 2014 | 46 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2019 | 638 | 0.100 |
Why?
|
| Health Literacy | 1 | 2016 | 130 | 0.100 |
Why?
|
| Southeastern United States | 1 | 2013 | 64 | 0.100 |
Why?
|
| Health Behavior | 2 | 2010 | 575 | 0.100 |
Why?
|
| Interinstitutional Relations | 1 | 2013 | 51 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 734 | 0.100 |
Why?
|
| Zebrafish Proteins | 2 | 2025 | 55 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 20 | 0.100 |
Why?
|
| Patient Care | 1 | 2013 | 31 | 0.100 |
Why?
|
| Spain | 1 | 2013 | 44 | 0.100 |
Why?
|
| Base Sequence | 1 | 2015 | 983 | 0.100 |
Why?
|
| Tissue Banks | 1 | 2012 | 9 | 0.100 |
Why?
|
| Patient Preference | 1 | 2013 | 60 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2025 | 1035 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1542 | 0.090 |
Why?
|
| Medically Underserved Area | 2 | 2011 | 120 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2016 | 587 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 207 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 638 | 0.090 |
Why?
|
| Program Development | 1 | 2012 | 240 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 91 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 138 | 0.080 |
Why?
|
| Skin Pigmentation | 1 | 2010 | 23 | 0.080 |
Why?
|
| Sunlight | 1 | 2010 | 48 | 0.080 |
Why?
|
| Foot | 1 | 2009 | 10 | 0.080 |
Why?
|
| Fear | 1 | 2012 | 272 | 0.080 |
Why?
|
| Defense Mechanisms | 1 | 2009 | 10 | 0.070 |
Why?
|
| School Health Services | 1 | 2010 | 90 | 0.070 |
Why?
|
| Problem Solving | 1 | 2009 | 38 | 0.070 |
Why?
|
| Medicare | 2 | 2008 | 332 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2009 | 1604 | 0.070 |
Why?
|
| Vaccination | 2 | 2021 | 355 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1019 | 0.060 |
Why?
|
| Perinatology | 1 | 2006 | 6 | 0.060 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2026 | 15 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2025 | 13 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2007 | 187 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2025 | 51 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 12 | 0.060 |
Why?
|
| Janus Kinases | 1 | 2025 | 23 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 972 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2025 | 21 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2009 | 469 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2025 | 61 | 0.050 |
Why?
|
| Logistic Models | 1 | 2007 | 1009 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 1600 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2026 | 239 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 224 | 0.050 |
Why?
|
| Trachea | 1 | 2023 | 25 | 0.050 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 21 | 0.050 |
Why?
|
| Exocytosis | 1 | 2023 | 49 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2023 | 100 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 78 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 386 | 0.050 |
Why?
|
| Diet | 1 | 2009 | 826 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 692 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 526 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 120 | 0.050 |
Why?
|
| Palliative Care | 1 | 2022 | 61 | 0.050 |
Why?
|
| Cytokines | 1 | 2026 | 678 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 7 | 0.050 |
Why?
|
| Algorithms | 1 | 2005 | 509 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 258 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 863 | 0.040 |
Why?
|
| Macrophages | 1 | 2026 | 529 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2021 | 49 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 389 | 0.040 |
Why?
|
| Protein Binding | 1 | 2025 | 1082 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 206 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2011 | 87 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 861 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 114 | 0.040 |
Why?
|
| Costs and Cost Analysis | 3 | 2011 | 60 | 0.040 |
Why?
|
| Direct Service Costs | 1 | 2000 | 1 | 0.040 |
Why?
|
| Workload | 1 | 2000 | 25 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 73 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 592 | 0.040 |
Why?
|
| Information Services | 1 | 2018 | 13 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1063 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2018 | 68 | 0.040 |
Why?
|
| TRPM Cation Channels | 1 | 2018 | 40 | 0.030 |
Why?
|
| Agriculture | 1 | 2018 | 66 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 200 | 0.030 |
Why?
|
| Peer Group | 1 | 2018 | 177 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 694 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2157 | 0.030 |
Why?
|
| Narration | 1 | 2016 | 37 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2015 | 60 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2014 | 25 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 110 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 154 | 0.030 |
Why?
|
| Poverty | 1 | 2016 | 400 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 518 | 0.020 |
Why?
|
| Translating | 1 | 2011 | 18 | 0.020 |
Why?
|
| Government Programs | 1 | 2011 | 29 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 148 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Health Promotion | 1 | 2016 | 704 | 0.020 |
Why?
|
| Sunscreening Agents | 1 | 2009 | 11 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 317 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fee-for-Service Plans | 1 | 2008 | 21 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2544 | 0.020 |
Why?
|
| SEER Program | 1 | 2008 | 164 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 490 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 133 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2005 | 43 | 0.010 |
Why?
|
| Insurance Claim Review | 1 | 2005 | 37 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 495 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2000 | 68 | 0.010 |
Why?
|
| Georgia | 1 | 2000 | 192 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 210 | 0.010 |
Why?
|
| Community Health Services | 1 | 2000 | 206 | 0.010 |
Why?
|